These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

233 related items for PubMed ID: 12588289

  • 21. Serological markers for gastric atrophy in asymptomatic patients infected with Helicobacter pylori.
    Ricci C, Vakil N, Rugge M, Gatta L, Perna F, Osborn JF, Russo VM, Tampieri A, Bernabucci V, Miglioli M, Vaira D.
    Am J Gastroenterol; 2004 Oct; 99(10):1910-5. PubMed ID: 15447749
    [Abstract] [Full Text] [Related]

  • 22. Serum chromogranin A as a screening test for gastric enterochromaffin-like cell hyperplasia during acid-suppressive therapy.
    Sanduleanu S, De Bruïne A, Stridsberg M, Jonkers D, Biemond I, Hameeteman W, Lundqvist G, Stockbrügger RW.
    Eur J Clin Invest; 2001 Sep; 31(9):802-11. PubMed ID: 11589723
    [Abstract] [Full Text] [Related]

  • 23. [Serological diagnosis of atrophic gastritis with a combination of pepsinogen I and II, gastrin-17 and anti-Helicobacter pylori antibodies].
    Valle Muñoz J, Artaza Varasa T, López Pardo R, Rodríguez Merlo R, Pérez Grueso MJ, Martín Escobedo R, Alcántara Torres M, Cuena Boy R, Carrobles Jiménez JM.
    Gastroenterol Hepatol; 2007 Dec; 30(10):567-71. PubMed ID: 18028850
    [Abstract] [Full Text] [Related]

  • 24. Serological Biomarker Panel in Diagnosis of Atrophic Gastritis and Helicobacter pylori Infection in Gastroscopy Referral Patients: Clinical Validation of the New-Generation GastroPanel® Test.
    Koivurova OP, Koskela R, Blomster T, Ala-Rämi A, Lumme H, Kettunen O, Hukkanen J, Karttunen TJ, Mäkinen M, Ronkainen J, Syrjänen K.
    Anticancer Res; 2021 Nov; 41(11):5527-5537. PubMed ID: 34732423
    [Abstract] [Full Text] [Related]

  • 25. Low Pepsinogen I/II Ratio and High Gastrin-17 Levels Typify Chronic Atrophic Autoimmune Gastritis Patients With Gastric Neuroendocrine Tumors.
    Magris R, De Re V, Maiero S, Fornasarig M, Guarnieri G, Caggiari L, Mazzon C, Zanette G, Steffan A, Canzonieri V, Cannizzaro R.
    Clin Transl Gastroenterol; 2020 Sep; 11(9):e00238. PubMed ID: 33094954
    [Abstract] [Full Text] [Related]

  • 26. Accuracy of serum pepsinogens I and II, gastrin-17 and anti-helicobacter pylori antibodies in histological diagnoses of atrophic gastritis.
    Irvani S, Hashemi MR, Moghadam KG, Saeidee S, Khavaran K, Najari O, Ranavardi M, Nasiri S, Salmasian H, Rohanizadegan M.
    Minerva Gastroenterol Dietol; 2010 Mar; 56(1):13-7. PubMed ID: 20190719
    [Abstract] [Full Text] [Related]

  • 27. Helicobacter pylori infection, but not mucosal atrophy, significantly affects serum pepsinogen level after gastric cancer surgery.
    Onoda N, Katsuragi K, Maeda K, Sawada T, Wakasa K, Hirakawa K.
    Hepatogastroenterology; 2006 Mar; 53(70):619-23. PubMed ID: 16995475
    [Abstract] [Full Text] [Related]

  • 28. Serum ghrelin as a marker of atrophic body gastritis in patients with parietal cell antibodies.
    Checchi S, Montanaro A, Pasqui L, Ciuoli C, Cevenini G, Sestini F, Fioravanti C, Pacini F.
    J Clin Endocrinol Metab; 2007 Nov; 92(11):4346-51. PubMed ID: 17711921
    [Abstract] [Full Text] [Related]

  • 29. Biomarkers in various types of atrophic gastritis and their diagnostic usefulness.
    Rembiasz K, Konturek PC, Karcz D, Konturek SJ, Ochmanski W, Bielanski W, Budzynski A, Stachura J.
    Dig Dis Sci; 2005 Mar; 50(3):474-82. PubMed ID: 15810629
    [Abstract] [Full Text] [Related]

  • 30. The potential value of serum pepsinogen for the diagnosis of atrophic gastritis among the health check-up populations in China: a diagnostic clinical research.
    Tong Y, Wu Y, Song Z, Yu Y, Yu X.
    BMC Gastroenterol; 2017 Jul 20; 17(1):88. PubMed ID: 28728545
    [Abstract] [Full Text] [Related]

  • 31. [Potentialities of a serological method in diagnosis of atrophic gastritis].
    Pimenov SI, Makarenko EV.
    Ter Arkh; 2008 Jul 20; 80(2):15-21. PubMed ID: 18372589
    [Abstract] [Full Text] [Related]

  • 32. Clinical usefulness of serum pepsinogens I and II, gastrin-17 and anti-Helicobacterpylori antibodies in the management of dyspeptic patients in primary care.
    Germaná B, Di Mario F, Cavallaro LG, Moussa AM, Lecis P, Liatoupolou S, Comparato G, Carloni C, Bertiato G, Battiestel M, Papa N, Aragona G, Cavestro GM, Iori V, Merli R, Bertolini S, Caruana P, Franzé A.
    Dig Liver Dis; 2005 Jul 20; 37(7):501-8. PubMed ID: 15975537
    [Abstract] [Full Text] [Related]

  • 33. Helicobacter pylori gastritis and serum pepsinogen levels in a healthy population: development of a biomarker strategy for gastric atrophy in high risk groups.
    Knight T, Wyatt J, Wilson A, Greaves S, Newell D, Hengels K, Corlett M, Webb P, Forman D, Elder J.
    Br J Cancer; 1996 Mar 20; 73(6):819-24. PubMed ID: 8611388
    [Abstract] [Full Text] [Related]

  • 34. Serum gastrin and pepsinogens do not correlate with the different grades of severity of gastro-oesophageal reflux disease: a matched case-control study.
    Monkemuller K, Neumann H, Nocon M, Vieth M, Labenz J, Willich SN, Stolte M, Hocker M, Jaspersen D, Lind T, Malfertheiner P.
    Aliment Pharmacol Ther; 2008 Aug 15; 28(4):491-6. PubMed ID: 18557987
    [Abstract] [Full Text] [Related]

  • 35. [Basal concentrations of gastrin and pepsinogen I and II in gastric ulcer: influence of Helicobacter pylori infection and usefulness in the control of the eradication].
    Bermejo F, Boixeda D, Gisbert JP, Sanz JM, Defarges V, Alvarez Calatayud G, Moreno L, Martín de Argila C.
    Gastroenterol Hepatol; 2001 Feb 15; 24(2):56-62. PubMed ID: 11247290
    [Abstract] [Full Text] [Related]

  • 36. [Relationship between pepsinogen I/II ratio and age or upper gastrointestinal diseases in Helicobacter pylori-positive and -negative subjects].
    Paik CN, Chung IS, Nam KW, Kwon JH, Chang JH, Suh JP, Park JM, Cho YK, Lee IS, Kim SW, Choi MG.
    Korean J Gastroenterol; 2007 Aug 15; 50(2):84-91. PubMed ID: 17928751
    [Abstract] [Full Text] [Related]

  • 37. Association of serum pepsinogen with atrophic body gastritis in Costa Rica.
    Sierra R, Une C, Ramírez V, González MI, Ramírez JA, de Mascarel A, Barahona R, Salas-Aguilar R, Páez R, Avendaño G, Avalos A, Broutet N, Mégraud F.
    Clin Exp Med; 2006 Jun 15; 6(2):72-8. PubMed ID: 16820994
    [Abstract] [Full Text] [Related]

  • 38. Serum biomarker tests are useful in delineating between patients with gastric atrophy and normal, healthy stomach.
    Iijima K, Abe Y, Kikuchi R, Koike T, Ohara S, Sipponen P, Shimosegawa T.
    World J Gastroenterol; 2009 Feb 21; 15(7):853-9. PubMed ID: 19230047
    [Abstract] [Full Text] [Related]

  • 39. Serum pepsinogens as a gastric cancer and gastritis biomarker in South and Southeast Asian populations.
    Miftahussurur M, Waskito LA, Aftab H, Vilaichone RK, Subsomwong P, Nusi IA, Syam AF, Ratanachu-Ek T, Doohan D, Siregar G, Rezkitha YAA, Fauzia KA, Mahachai V, Yamaoka Y.
    PLoS One; 2020 Feb 21; 15(4):e0230064. PubMed ID: 32271765
    [Abstract] [Full Text] [Related]

  • 40. Serum levels of amidated gastrin-17 and pepsinogen I in atrophic gastritis: an observational case-control study.
    Sipponen P, Ranta P, Helske T, Kääriäinen I, Mäki T, Linnala A, Suovaniemi O, Alanko A, Härkönen M.
    Scand J Gastroenterol; 2002 Jul 21; 37(7):785-91. PubMed ID: 12190091
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.